AdvanCell to Present Promising Clinical Trial Results of ADVC001, a Novel Lead-212-based PSMA-targeted Alpha Therapy for Prostate Cancer, at ESMO 2025
Results from the Phase 1b dose escalation of the TheraPb Phase 1/2 trial are the first clinical data for a Lead-212 (212Pb)-based-PSMA radioligand therapy The abstract... Read more.
Natera to Present 14 Studies at ESMO, Including IMvigor011 Oral Presentation in Presidential Symposium
Six oral presentations highlight Signatera’s expanding role across solid tumors, including definitive predictive data in adjuvant bladder cancer AUSTIN, Texas–(BUSINESS... Read more.
Anti-TIGIT Domvanalimab Plus Anti-PD-1 Zimberelimab and Chemotherapy Showed 26.7 Months of Median Overall Survival as First-Line Treatment of Unresectable or Advanced Gastroesophageal Adenocarcinomas in the Phase 2 EDGE-Gastric Study
First overall survival (OS) results from Arm A1 of the Phase 2 EDGE-Gastric study will be presented on October 18 at the European Society for Medical Oncology (ESMO)... Read more.
Data from Incyte’s TGFβR2×PD-1 Bispecific Antibody and KRAS G12D Inhibitor to be Presented at the European Society of Medical Oncology (ESMO) Congress 2025
WILMINGTON, Del.–(BUSINESS WIRE)–$INCY #ESMO2025–Incyte (Nasdaq:INCY) today announced that results from Phase 1 proof-of-concept studies of INCA33890,... Read more.
AHF Commends Gov. Newsom for Signing PBM Reform Bill (SB 41, Weiner)
Legislation reforms will rein in drug middlemen abuses LOS ANGELES–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) thanked California Governor Gavin... Read more.
HITN Takes Home Emmy® Honors at the 68th New York Emmy® Awards
Link to IMAGES BROOKLYN, N.Y.–(BUSINESS WIRE)–#HITNWins—HITN, the leading Spanish-language public media network, proudly took home three awards... Read more.
Leonardo DRS Unveils SAGEcore™ Ruggedized AI Software Platform for Real-time Threat Detection and Decision Support at the Tactical Edge
Software platform uses AI and machine learning for rapid fusing of complex data into shared, real-time view of battlespace for faster, smarter and safer action under... Read more.
INVESTOR DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of WPP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In WPP To Contact Him Directly To Discuss Their... Read more.
INVESTOR DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In aTyr To Contact Him Directly To Discuss Their... Read more.
Stitch Fix, Inc. Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – SFIX
LOS ANGELES–(BUSINESS WIRE)–The DJS Law Group announces that it is investigating claims on behalf of investors of Stitch Fix, Inc. (“Stitch Fix”... Read more.